Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

YSELTY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/YSELTY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

YSELTY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Theramex Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 28, 2023
Approval ID: de1e9787051d6cc7
Company: Theramex Ireland Limited
Type: Standard

Approval Details

Approval Id: de1e9787051d6cc7
Drug Cima Aemps Name: YSELTY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1211606002
Holder Company Name: Theramex Ireland Limited
Marketing Company Name: Theramex Ireland Limited
Holder Company Detail Path: /organization/theramex-ireland-ltd
Marketing Company Detail Path: /organization/theramex-ireland-ltd
Authorization Date: 2023-06-28
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 200 MG
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Theramex Ireland Limited
Company Detail Path: /organization/theramex-ireland-ltd

Company Information

Pharmaceutical Company Name: Theramex Ireland Ltd.
Country Name: Ireland

Active Ingredients

LINZAGOLIX COLINA

240,60 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 28, 2023

Approval ID

de1e9787051d6cc7

Type

Standard

Back to CIMA-AEMPS Approvals